MedTrace Logo

Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control as a Means of Reducing Excess Body Weight

NCT04110717 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-04-03

No results posted yet for this study

Summary

A randomized, double blind sham controlled clinical trial to evaluate the efficacy of vestibular nerve stimulation (VeNS), together with a lifestyle modification program, compared to a sham control with a lifestyle modification programme, as a means of reducing excess body weight and body fat.

Conditions

Interventions

DEVICE

Vestal Device

Vestibular nerve stimulator

DEVICE

Control Device

Control Device

BEHAVIORAL

Hypocaloric Diet

Hypocaloric diet

Sponsors & Collaborators

  • University College Dublin

    collaborator OTHER

  • Exploristics Ltd

    collaborator UNKNOWN

  • Compliance Solutions Ltd.

    collaborator INDUSTRY

  • Neurovalens Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-09
Primary Completion
2021-03-23
Completion
2021-03-23

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04110717 on ClinicalTrials.gov